TY - JOUR AB - We developed a competition-based screening strategy to identify compounds that invert the selective advantage of antibiotic resistance. Using our assay, we screened over 19,000 compounds for the ability to select against the TetA tetracycline-resistance efflux pump in Escherichia coli and identified two hits, β-thujaplicin and disulfiram. Treating a tetracycline-resistant population with β-thujaplicin selects for loss of the resistance gene, enabling an effective second-phase treatment with doxycycline. AU - Stone, Laura AU - Baym, Michael AU - Lieberman, Tami AU - Chait, Remy P AU - Clardy, Jon AU - Kishony, Roy ID - 1290 IS - 11 JF - Nature Chemical Biology TI - Compounds that select against the tetracycline-resistance efflux pump VL - 12 ER -